At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
ADIL Adial Pharmaceuticals
Trading 02-25 11:32:13 EST
2.52
+0.08
+3.08%
High2.63
Low2.40
Vol23.46K
Open2.44
D1 Closing2.44
Amplitude9.62%
Mkt Cap2.79M
Tradable Cap2.67M
Total Shares1.11M
T/O58.04K
T/O Rate2.21%
Tradable Shares1.06M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
BRIEF-Adial Pharmaceuticals Regains Full Compliance With Nasdaq Listing Requirement
Adial Applauds Congressional Directive Advancing Alternative Clinical Trial Endpoints for Substance Use Disorders, Strengthening Regulatory Path for AD04
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. The company was founded in 2010 and is based in Glen Allen, Virginia.